nodes	percent_of_prediction	percent_of_DWPC	metapath
Perphenazine—HTR2C—Sorafenib—liver cancer	0.138	0.23	CbGbCtD
Perphenazine—CYP2B6—Sorafenib—liver cancer	0.0858	0.143	CbGbCtD
Perphenazine—CYP2C8—Sorafenib—liver cancer	0.065	0.108	CbGbCtD
Perphenazine—CYP2C19—Sorafenib—liver cancer	0.0545	0.0908	CbGbCtD
Perphenazine—CYP2B6—Doxorubicin—liver cancer	0.0521	0.0867	CbGbCtD
Perphenazine—CYP1A2—Sorafenib—liver cancer	0.0503	0.0838	CbGbCtD
Perphenazine—CYP2C9—Sorafenib—liver cancer	0.0453	0.0755	CbGbCtD
Perphenazine—CYP2D6—Sorafenib—liver cancer	0.0415	0.0691	CbGbCtD
Perphenazine—CYP3A4—Sorafenib—liver cancer	0.0264	0.0439	CbGbCtD
Perphenazine—CYP2D6—Doxorubicin—liver cancer	0.0252	0.0419	CbGbCtD
Perphenazine—CYP3A4—Doxorubicin—liver cancer	0.016	0.0266	CbGbCtD
Perphenazine—Oropharyngeal discomfort—Sorafenib—liver cancer	0.00303	0.0313	CcSEcCtD
Perphenazine—Faecalith—Epirubicin—liver cancer	0.00285	0.0294	CcSEcCtD
Perphenazine—Faecaloma—Epirubicin—liver cancer	0.00285	0.0294	CcSEcCtD
Perphenazine—Faecalith—Doxorubicin—liver cancer	0.00263	0.0272	CcSEcCtD
Perphenazine—Faecaloma—Doxorubicin—liver cancer	0.00263	0.0272	CcSEcCtD
Perphenazine—Gynaecomastia—Sorafenib—liver cancer	0.00197	0.0204	CcSEcCtD
Perphenazine—Eczema—Sorafenib—liver cancer	0.00178	0.0184	CcSEcCtD
Perphenazine—Dermatitis exfoliative—Sorafenib—liver cancer	0.00169	0.0175	CcSEcCtD
Perphenazine—Dysphagia—Sorafenib—liver cancer	0.00138	0.0143	CcSEcCtD
Perphenazine—Jaundice—Sorafenib—liver cancer	0.0012	0.0124	CcSEcCtD
Perphenazine—Glycosuria—Epirubicin—liver cancer	0.001	0.0104	CcSEcCtD
Perphenazine—Blood disorder—Epirubicin—liver cancer	0.000974	0.0101	CcSEcCtD
Perphenazine—Liver injury—Epirubicin—liver cancer	0.000967	0.01	CcSEcCtD
Perphenazine—Erythema—Sorafenib—liver cancer	0.000963	0.00995	CcSEcCtD
Perphenazine—Glycosuria—Doxorubicin—liver cancer	0.000929	0.00961	CcSEcCtD
Perphenazine—Jaundice cholestatic—Epirubicin—liver cancer	0.000926	0.00958	CcSEcCtD
Perphenazine—Amenorrhoea—Epirubicin—liver cancer	0.000926	0.00958	CcSEcCtD
Perphenazine—Muscle spasms—Sorafenib—liver cancer	0.000925	0.00957	CcSEcCtD
Perphenazine—Blood disorder—Doxorubicin—liver cancer	0.000902	0.00932	CcSEcCtD
Perphenazine—Liver injury—Doxorubicin—liver cancer	0.000895	0.00925	CcSEcCtD
Perphenazine—Angioedema—Sorafenib—liver cancer	0.00088	0.00909	CcSEcCtD
Perphenazine—Dyskinesia—Epirubicin—liver cancer	0.000866	0.00895	CcSEcCtD
Perphenazine—Syncope—Sorafenib—liver cancer	0.000863	0.00893	CcSEcCtD
Perphenazine—Leukopenia—Sorafenib—liver cancer	0.000862	0.00891	CcSEcCtD
Perphenazine—Dysarthria—Epirubicin—liver cancer	0.00086	0.0089	CcSEcCtD
Perphenazine—Jaundice cholestatic—Doxorubicin—liver cancer	0.000857	0.00886	CcSEcCtD
Perphenazine—Amenorrhoea—Doxorubicin—liver cancer	0.000857	0.00886	CcSEcCtD
Perphenazine—Loss of consciousness—Sorafenib—liver cancer	0.000846	0.00875	CcSEcCtD
Perphenazine—Cough—Sorafenib—liver cancer	0.00084	0.00869	CcSEcCtD
Perphenazine—Hypertension—Sorafenib—liver cancer	0.000831	0.00859	CcSEcCtD
Perphenazine—Hepatocellular injury—Epirubicin—liver cancer	0.000814	0.00841	CcSEcCtD
Perphenazine—Abnormal dreams—Epirubicin—liver cancer	0.000804	0.00832	CcSEcCtD
Perphenazine—Dermatitis contact—Epirubicin—liver cancer	0.000804	0.00832	CcSEcCtD
Perphenazine—Dry mouth—Sorafenib—liver cancer	0.000801	0.00829	CcSEcCtD
Perphenazine—Dyskinesia—Doxorubicin—liver cancer	0.000801	0.00828	CcSEcCtD
Perphenazine—Dysarthria—Doxorubicin—liver cancer	0.000796	0.00823	CcSEcCtD
Perphenazine—Salivary hypersecretion—Epirubicin—liver cancer	0.00079	0.00817	CcSEcCtD
Perphenazine—Anaphylactic shock—Sorafenib—liver cancer	0.000786	0.00812	CcSEcCtD
Perphenazine—Infection—Sorafenib—liver cancer	0.00078	0.00807	CcSEcCtD
Perphenazine—Shock—Sorafenib—liver cancer	0.000773	0.00799	CcSEcCtD
Perphenazine—Hepatocellular injury—Doxorubicin—liver cancer	0.000753	0.00779	CcSEcCtD
Perphenazine—Anorexia—Sorafenib—liver cancer	0.000749	0.00774	CcSEcCtD
Perphenazine—Abnormal dreams—Doxorubicin—liver cancer	0.000744	0.00769	CcSEcCtD
Perphenazine—Dermatitis contact—Doxorubicin—liver cancer	0.000744	0.00769	CcSEcCtD
Perphenazine—Salivary hypersecretion—Doxorubicin—liver cancer	0.000731	0.00756	CcSEcCtD
Perphenazine—Dyspnoea—Sorafenib—liver cancer	0.0007	0.00724	CcSEcCtD
Perphenazine—Decreased appetite—Sorafenib—liver cancer	0.000683	0.00706	CcSEcCtD
Perphenazine—Photosensitivity—Epirubicin—liver cancer	0.000673	0.00696	CcSEcCtD
Perphenazine—Constipation—Sorafenib—liver cancer	0.000672	0.00695	CcSEcCtD
Perphenazine—Pain—Sorafenib—liver cancer	0.000672	0.00695	CcSEcCtD
Perphenazine—Eczema—Epirubicin—liver cancer	0.000657	0.0068	CcSEcCtD
Perphenazine—Dermatitis exfoliative—Epirubicin—liver cancer	0.000626	0.00647	CcSEcCtD
Perphenazine—Urticaria—Sorafenib—liver cancer	0.000624	0.00645	CcSEcCtD
Perphenazine—Photosensitivity—Doxorubicin—liver cancer	0.000622	0.00644	CcSEcCtD
Perphenazine—Body temperature increased—Sorafenib—liver cancer	0.000621	0.00642	CcSEcCtD
Perphenazine—Anaphylactoid reaction—Epirubicin—liver cancer	0.00061	0.00631	CcSEcCtD
Perphenazine—Eczema—Doxorubicin—liver cancer	0.000608	0.00629	CcSEcCtD
Perphenazine—Hypoglycaemia—Epirubicin—liver cancer	0.000605	0.00626	CcSEcCtD
Perphenazine—Lethargy—Epirubicin—liver cancer	0.000603	0.00623	CcSEcCtD
Perphenazine—Dermatitis exfoliative—Doxorubicin—liver cancer	0.000579	0.00599	CcSEcCtD
Perphenazine—Hypersensitivity—Sorafenib—liver cancer	0.000579	0.00598	CcSEcCtD
Perphenazine—Anaphylactoid reaction—Doxorubicin—liver cancer	0.000565	0.00584	CcSEcCtD
Perphenazine—Cardiac arrest—Epirubicin—liver cancer	0.000562	0.00581	CcSEcCtD
Perphenazine—Hypoglycaemia—Doxorubicin—liver cancer	0.00056	0.00579	CcSEcCtD
Perphenazine—Lethargy—Doxorubicin—liver cancer	0.000558	0.00577	CcSEcCtD
Perphenazine—Pruritus—Sorafenib—liver cancer	0.000556	0.00575	CcSEcCtD
Perphenazine—Ataxia—Epirubicin—liver cancer	0.000555	0.00574	CcSEcCtD
Perphenazine—Orthostatic hypotension—Epirubicin—liver cancer	0.00054	0.00558	CcSEcCtD
Perphenazine—Diarrhoea—Sorafenib—liver cancer	0.000538	0.00556	CcSEcCtD
Perphenazine—Clomipramine—GSTP1—liver cancer	0.000521	0.209	CrCbGaD
Perphenazine—Muscular weakness—Epirubicin—liver cancer	0.000521	0.00539	CcSEcCtD
Perphenazine—Cardiac arrest—Doxorubicin—liver cancer	0.00052	0.00537	CcSEcCtD
Perphenazine—Dizziness—Sorafenib—liver cancer	0.000519	0.00537	CcSEcCtD
Perphenazine—Ataxia—Doxorubicin—liver cancer	0.000514	0.00531	CcSEcCtD
Perphenazine—Asthma—Epirubicin—liver cancer	0.000511	0.00528	CcSEcCtD
Perphenazine—Dysphagia—Epirubicin—liver cancer	0.000511	0.00528	CcSEcCtD
Perphenazine—Eosinophilia—Epirubicin—liver cancer	0.000506	0.00523	CcSEcCtD
Perphenazine—Orthostatic hypotension—Doxorubicin—liver cancer	0.000499	0.00516	CcSEcCtD
Perphenazine—Headache—Sorafenib—liver cancer	0.000492	0.00509	CcSEcCtD
Perphenazine—Pancytopenia—Epirubicin—liver cancer	0.000485	0.00501	CcSEcCtD
Perphenazine—Muscular weakness—Doxorubicin—liver cancer	0.000482	0.00498	CcSEcCtD
Perphenazine—Asthma—Doxorubicin—liver cancer	0.000472	0.00488	CcSEcCtD
Perphenazine—Dysphagia—Doxorubicin—liver cancer	0.000472	0.00488	CcSEcCtD
Perphenazine—Eosinophilia—Doxorubicin—liver cancer	0.000468	0.00484	CcSEcCtD
Perphenazine—Photosensitivity reaction—Epirubicin—liver cancer	0.000466	0.00482	CcSEcCtD
Perphenazine—Hyperglycaemia—Epirubicin—liver cancer	0.000461	0.00476	CcSEcCtD
Perphenazine—Drowsiness—Epirubicin—liver cancer	0.000455	0.00471	CcSEcCtD
Perphenazine—Pancytopenia—Doxorubicin—liver cancer	0.000449	0.00464	CcSEcCtD
Perphenazine—Jaundice—Epirubicin—liver cancer	0.000444	0.00459	CcSEcCtD
Perphenazine—Photosensitivity reaction—Doxorubicin—liver cancer	0.000431	0.00446	CcSEcCtD
Perphenazine—Hyperglycaemia—Doxorubicin—liver cancer	0.000426	0.00441	CcSEcCtD
Perphenazine—Agranulocytosis—Epirubicin—liver cancer	0.000425	0.00439	CcSEcCtD
Perphenazine—Drowsiness—Doxorubicin—liver cancer	0.000421	0.00436	CcSEcCtD
Perphenazine—Bradycardia—Epirubicin—liver cancer	0.000416	0.0043	CcSEcCtD
Perphenazine—Jaundice—Doxorubicin—liver cancer	0.000411	0.00425	CcSEcCtD
Perphenazine—Hypoaesthesia—Epirubicin—liver cancer	0.000407	0.0042	CcSEcCtD
Perphenazine—Oedema peripheral—Epirubicin—liver cancer	0.000403	0.00416	CcSEcCtD
Perphenazine—Agranulocytosis—Doxorubicin—liver cancer	0.000393	0.00406	CcSEcCtD
Perphenazine—Bradycardia—Doxorubicin—liver cancer	0.000385	0.00398	CcSEcCtD
Perphenazine—Hypoaesthesia—Doxorubicin—liver cancer	0.000376	0.00389	CcSEcCtD
Perphenazine—Oedema peripheral—Doxorubicin—liver cancer	0.000372	0.00385	CcSEcCtD
Perphenazine—Erythema—Epirubicin—liver cancer	0.000356	0.00368	CcSEcCtD
Perphenazine—Muscle spasms—Epirubicin—liver cancer	0.000342	0.00354	CcSEcCtD
Perphenazine—Vision blurred—Epirubicin—liver cancer	0.000335	0.00347	CcSEcCtD
Perphenazine—Erythema—Doxorubicin—liver cancer	0.000329	0.0034	CcSEcCtD
Perphenazine—Agitation—Epirubicin—liver cancer	0.000327	0.00338	CcSEcCtD
Perphenazine—Syncope—Epirubicin—liver cancer	0.000319	0.0033	CcSEcCtD
Perphenazine—Leukopenia—Epirubicin—liver cancer	0.000318	0.00329	CcSEcCtD
Perphenazine—Muscle spasms—Doxorubicin—liver cancer	0.000316	0.00327	CcSEcCtD
Perphenazine—Loss of consciousness—Epirubicin—liver cancer	0.000313	0.00323	CcSEcCtD
Perphenazine—Cough—Epirubicin—liver cancer	0.00031	0.00321	CcSEcCtD
Perphenazine—Vision blurred—Doxorubicin—liver cancer	0.00031	0.00321	CcSEcCtD
Perphenazine—Convulsion—Epirubicin—liver cancer	0.000308	0.00319	CcSEcCtD
Perphenazine—Hypertension—Epirubicin—liver cancer	0.000307	0.00318	CcSEcCtD
Perphenazine—Agitation—Doxorubicin—liver cancer	0.000302	0.00313	CcSEcCtD
Perphenazine—Dry mouth—Epirubicin—liver cancer	0.000296	0.00306	CcSEcCtD
Perphenazine—Syncope—Doxorubicin—liver cancer	0.000295	0.00305	CcSEcCtD
Perphenazine—Leukopenia—Doxorubicin—liver cancer	0.000295	0.00305	CcSEcCtD
Perphenazine—Confusional state—Epirubicin—liver cancer	0.000293	0.00303	CcSEcCtD
Perphenazine—Fluphenazine—CYP2E1—liver cancer	0.000292	0.117	CrCbGaD
Perphenazine—Anaphylactic shock—Epirubicin—liver cancer	0.00029	0.003	CcSEcCtD
Perphenazine—Loss of consciousness—Doxorubicin—liver cancer	0.000289	0.00299	CcSEcCtD
Perphenazine—Infection—Epirubicin—liver cancer	0.000288	0.00298	CcSEcCtD
Perphenazine—Cough—Doxorubicin—liver cancer	0.000287	0.00297	CcSEcCtD
Perphenazine—Shock—Epirubicin—liver cancer	0.000286	0.00295	CcSEcCtD
Perphenazine—Convulsion—Doxorubicin—liver cancer	0.000285	0.00295	CcSEcCtD
Perphenazine—Hypertension—Doxorubicin—liver cancer	0.000284	0.00294	CcSEcCtD
Perphenazine—Tachycardia—Epirubicin—liver cancer	0.000283	0.00293	CcSEcCtD
Perphenazine—Anorexia—Epirubicin—liver cancer	0.000277	0.00286	CcSEcCtD
Perphenazine—Dry mouth—Doxorubicin—liver cancer	0.000274	0.00283	CcSEcCtD
Perphenazine—Hypotension—Epirubicin—liver cancer	0.000271	0.00281	CcSEcCtD
Perphenazine—Confusional state—Doxorubicin—liver cancer	0.000271	0.0028	CcSEcCtD
Perphenazine—Anaphylactic shock—Doxorubicin—liver cancer	0.000269	0.00278	CcSEcCtD
Perphenazine—Infection—Doxorubicin—liver cancer	0.000267	0.00276	CcSEcCtD
Perphenazine—Shock—Doxorubicin—liver cancer	0.000264	0.00273	CcSEcCtD
Perphenazine—Insomnia—Epirubicin—liver cancer	0.000263	0.00272	CcSEcCtD
Perphenazine—Tachycardia—Doxorubicin—liver cancer	0.000262	0.00271	CcSEcCtD
Perphenazine—Dyspnoea—Epirubicin—liver cancer	0.000259	0.00268	CcSEcCtD
Perphenazine—Somnolence—Epirubicin—liver cancer	0.000258	0.00267	CcSEcCtD
Perphenazine—Anorexia—Doxorubicin—liver cancer	0.000256	0.00265	CcSEcCtD
Perphenazine—Decreased appetite—Epirubicin—liver cancer	0.000252	0.00261	CcSEcCtD
Perphenazine—Thioridazine—CYP2E1—liver cancer	0.000252	0.101	CrCbGaD
Perphenazine—Hypotension—Doxorubicin—liver cancer	0.000251	0.0026	CcSEcCtD
Perphenazine—Constipation—Epirubicin—liver cancer	0.000248	0.00257	CcSEcCtD
Perphenazine—Pain—Epirubicin—liver cancer	0.000248	0.00257	CcSEcCtD
Perphenazine—Insomnia—Doxorubicin—liver cancer	0.000243	0.00251	CcSEcCtD
Perphenazine—Methotrimeprazine—CYP2E1—liver cancer	0.000241	0.0965	CrCbGaD
Perphenazine—Dyspnoea—Doxorubicin—liver cancer	0.00024	0.00248	CcSEcCtD
Perphenazine—Somnolence—Doxorubicin—liver cancer	0.000239	0.00247	CcSEcCtD
Perphenazine—Decreased appetite—Doxorubicin—liver cancer	0.000234	0.00241	CcSEcCtD
Perphenazine—Urticaria—Epirubicin—liver cancer	0.000231	0.00238	CcSEcCtD
Perphenazine—Constipation—Doxorubicin—liver cancer	0.00023	0.00238	CcSEcCtD
Perphenazine—Pain—Doxorubicin—liver cancer	0.00023	0.00238	CcSEcCtD
Perphenazine—Body temperature increased—Epirubicin—liver cancer	0.00023	0.00237	CcSEcCtD
Perphenazine—Hypersensitivity—Epirubicin—liver cancer	0.000214	0.00221	CcSEcCtD
Perphenazine—Urticaria—Doxorubicin—liver cancer	0.000213	0.00221	CcSEcCtD
Perphenazine—Body temperature increased—Doxorubicin—liver cancer	0.000212	0.0022	CcSEcCtD
Perphenazine—Pruritus—Epirubicin—liver cancer	0.000205	0.00212	CcSEcCtD
Perphenazine—Diarrhoea—Epirubicin—liver cancer	0.000199	0.00205	CcSEcCtD
Perphenazine—Hypersensitivity—Doxorubicin—liver cancer	0.000198	0.00205	CcSEcCtD
Perphenazine—Acepromazine—ALB—liver cancer	0.000193	0.0776	CrCbGaD
Perphenazine—Dizziness—Epirubicin—liver cancer	0.000192	0.00199	CcSEcCtD
Perphenazine—Pruritus—Doxorubicin—liver cancer	0.00019	0.00197	CcSEcCtD
Perphenazine—Thioproperazine—ALB—liver cancer	0.000189	0.0758	CrCbGaD
Perphenazine—Pipotiazine—ALB—liver cancer	0.000186	0.0746	CrCbGaD
Perphenazine—Thiothixene—ALB—liver cancer	0.000186	0.0746	CrCbGaD
Perphenazine—Diarrhoea—Doxorubicin—liver cancer	0.000184	0.0019	CcSEcCtD
Perphenazine—Chlorpromazine—CYP2E1—liver cancer	0.000183	0.0736	CrCbGaD
Perphenazine—Headache—Epirubicin—liver cancer	0.000182	0.00188	CcSEcCtD
Perphenazine—Dizziness—Doxorubicin—liver cancer	0.000178	0.00184	CcSEcCtD
Perphenazine—Headache—Doxorubicin—liver cancer	0.000168	0.00174	CcSEcCtD
Perphenazine—Clomipramine—ALB—liver cancer	0.000147	0.059	CrCbGaD
Perphenazine—Chlorpromazine—ALB—liver cancer	0.000101	0.0404	CrCbGaD
Perphenazine—DRD2—Signaling Pathways—CDKN1A—liver cancer	7.55e-06	2.51e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—HMOX1—liver cancer	7.5e-06	2.5e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—ALB—liver cancer	7.48e-06	2.49e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—MMP9—liver cancer	7.45e-06	2.48e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling by GPCR—HRAS—liver cancer	7.45e-06	2.48e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—MMP9—liver cancer	7.44e-06	2.47e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—CDKN1A—liver cancer	7.43e-06	2.47e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—CDKN1A—liver cancer	7.41e-06	2.47e-05	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—PIK3CB—liver cancer	7.4e-06	2.46e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—MAPK8—liver cancer	7.37e-06	2.45e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling by GPCR—AKT1—liver cancer	7.35e-06	2.44e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—PIK3CA—liver cancer	7.34e-06	2.44e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—CDKN1B—liver cancer	7.32e-06	2.44e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—KRAS—liver cancer	7.3e-06	2.43e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—MYC—liver cancer	7.3e-06	2.43e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—RAF1—liver cancer	7.29e-06	2.43e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—TGFB1—liver cancer	7.28e-06	2.42e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—MAPK8—liver cancer	7.25e-06	2.41e-05	CbGpPWpGaD
Perphenazine—ADRA2A—GPCR downstream signaling—AKT1—liver cancer	7.24e-06	2.41e-05	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—IL6—liver cancer	7.24e-06	2.41e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—MAPK8—liver cancer	7.23e-06	2.41e-05	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—IL6—liver cancer	7.23e-06	2.41e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling by GPCR—AKT1—liver cancer	7.23e-06	2.41e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling by GPCR—AKT1—liver cancer	7.21e-06	2.4e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—CASP3—liver cancer	7.17e-06	2.39e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—IL2—liver cancer	7.16e-06	2.38e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling by GPCR—IL6—liver cancer	7.13e-06	2.37e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—MYC—liver cancer	7.13e-06	2.37e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—PIK3CB—liver cancer	7.12e-06	2.37e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—MTOR—liver cancer	7.12e-06	2.37e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—TGFB1—liver cancer	7.11e-06	2.37e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—PIK3CA—liver cancer	7.1e-06	2.36e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—PIK3CA—liver cancer	7.1e-06	2.36e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—MYC—liver cancer	7.09e-06	2.36e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—TGFB1—liver cancer	7.07e-06	2.35e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—KRAS—liver cancer	7.07e-06	2.35e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—KRAS—liver cancer	7.07e-06	2.35e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—MYC—liver cancer	7.06e-06	2.35e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—MYC—liver cancer	7.06e-06	2.35e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—RAF1—liver cancer	7.05e-06	2.35e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—RAF1—liver cancer	7.05e-06	2.35e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	7.05e-06	2.35e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—TGFB1—liver cancer	7.04e-06	2.34e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—TGFB1—liver cancer	7.04e-06	2.34e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—PIK3CA—liver cancer	7.04e-06	2.34e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—GSTM1—liver cancer	6.98e-06	2.32e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—CCND1—liver cancer	6.98e-06	2.32e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—PIK3CD—liver cancer	6.97e-06	2.32e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—JUN—liver cancer	6.97e-06	2.32e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—CTNNB1—liver cancer	6.92e-06	2.3e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—PIK3CD—liver cancer	6.91e-06	2.3e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—PIK3CB—liver cancer	6.88e-06	2.29e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—MTOR—liver cancer	6.88e-06	2.29e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—MTOR—liver cancer	6.88e-06	2.29e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—PIK3CB—liver cancer	6.88e-06	2.29e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—ALB—liver cancer	6.88e-06	2.29e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—ALB—liver cancer	6.82e-06	2.27e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—TP53—liver cancer	6.81e-06	2.27e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—VEGFA—liver cancer	6.8e-06	2.26e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—HRAS—liver cancer	6.79e-06	2.26e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—MMP9—liver cancer	6.78e-06	2.26e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—CDKN1A—liver cancer	6.76e-06	2.25e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—KRAS—liver cancer	6.74e-06	2.24e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—STAT3—liver cancer	6.73e-06	2.24e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—PIK3CG—liver cancer	6.72e-06	2.24e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—PIK3CA—liver cancer	6.71e-06	2.23e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—VEGFA—liver cancer	6.69e-06	2.23e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CDKN1B—liver cancer	6.68e-06	2.22e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—VEGFA—liver cancer	6.68e-06	2.22e-05	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—AKT1—liver cancer	6.68e-06	2.22e-05	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—AKT1—liver cancer	6.67e-06	2.22e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—STAT3—liver cancer	6.63e-06	2.21e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—CYP1A1—liver cancer	6.62e-06	2.2e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—STAT3—liver cancer	6.61e-06	2.2e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—PIK3CB—liver cancer	6.61e-06	2.2e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—MAPK8—liver cancer	6.59e-06	2.19e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—KRAS—liver cancer	6.58e-06	2.19e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling by GPCR—AKT1—liver cancer	6.58e-06	2.19e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—HRAS—liver cancer	6.57e-06	2.19e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—HRAS—liver cancer	6.57e-06	2.19e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—KRAS—liver cancer	6.55e-06	2.18e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CASP3—liver cancer	6.55e-06	2.18e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—IL2—liver cancer	6.54e-06	2.18e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—KRAS—liver cancer	6.52e-06	2.17e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—KRAS—liver cancer	6.52e-06	2.17e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—HRAS—liver cancer	6.51e-06	2.17e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—IL6—liver cancer	6.5e-06	2.16e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—PIK3CA—liver cancer	6.49e-06	2.16e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—PIK3CA—liver cancer	6.49e-06	2.16e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—PPARG—liver cancer	6.49e-06	2.16e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CDKN1B—liver cancer	6.46e-06	2.15e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CDKN1B—liver cancer	6.46e-06	2.15e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CCND1—liver cancer	6.37e-06	2.12e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—JUN—liver cancer	6.36e-06	2.12e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CASP3—liver cancer	6.33e-06	2.11e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CASP3—liver cancer	6.33e-06	2.11e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—IL2—liver cancer	6.32e-06	2.1e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—IL2—liver cancer	6.32e-06	2.1e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CTNNB1—liver cancer	6.31e-06	2.1e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—IL6—liver cancer	6.29e-06	2.09e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—IL6—liver cancer	6.29e-06	2.09e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—MYC—liver cancer	6.26e-06	2.08e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—TGFB1—liver cancer	6.24e-06	2.08e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—IL6—liver cancer	6.23e-06	2.07e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—HRAS—liver cancer	6.21e-06	2.07e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—PIK3CA—liver cancer	6.2e-06	2.06e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—MMP9—liver cancer	6.19e-06	2.06e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—MTHFR—liver cancer	6.17e-06	2.05e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CDKN1A—liver cancer	6.16e-06	2.05e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CCND1—liver cancer	6.16e-06	2.05e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CCND1—liver cancer	6.16e-06	2.05e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—MYC—liver cancer	6.16e-06	2.05e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—JUN—liver cancer	6.15e-06	2.05e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—JUN—liver cancer	6.15e-06	2.05e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—MYC—liver cancer	6.14e-06	2.04e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—TGFB1—liver cancer	6.14e-06	2.04e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—TGFB1—liver cancer	6.13e-06	2.04e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CTNNB1—liver cancer	6.1e-06	2.03e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CTNNB1—liver cancer	6.1e-06	2.03e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—VEGFA—liver cancer	6.09e-06	2.03e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—PIK3CB—liver cancer	6.08e-06	2.02e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PPARA—liver cancer	6.06e-06	2.02e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—PIK3CA—liver cancer	6.05e-06	2.01e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—STAT3—liver cancer	6.03e-06	2.01e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—PIK3CB—liver cancer	6.03e-06	2.01e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—PIK3CA—liver cancer	6.02e-06	2e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—MAPK8—liver cancer	6.02e-06	2e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—HRAS—liver cancer	6.01e-06	2e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—HRAS—liver cancer	6.01e-06	2e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—AKT1—liver cancer	6e-06	2e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—PIK3CA—liver cancer	5.99e-06	1.99e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—PIK3CA—liver cancer	5.99e-06	1.99e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—MMP9—liver cancer	5.98e-06	1.99e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—MMP9—liver cancer	5.98e-06	1.99e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CDKN1A—liver cancer	5.96e-06	1.98e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CDKN1A—liver cancer	5.96e-06	1.98e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—IL6—liver cancer	5.94e-06	1.98e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—PIK3CD—liver cancer	5.91e-06	1.97e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—TP53—liver cancer	5.85e-06	1.95e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—ALB—liver cancer	5.83e-06	1.94e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—TP53—liver cancer	5.82e-06	1.94e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—MAPK8—liver cancer	5.82e-06	1.94e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—MAPK8—liver cancer	5.82e-06	1.94e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—AKT1—liver cancer	5.8e-06	1.93e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—AKT1—liver cancer	5.8e-06	1.93e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—KRAS—liver cancer	5.78e-06	1.92e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—IL6—liver cancer	5.75e-06	1.91e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—IL6—liver cancer	5.75e-06	1.91e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—AKT1—liver cancer	5.75e-06	1.91e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—HRAS—liver cancer	5.73e-06	1.91e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—KRAS—liver cancer	5.69e-06	1.89e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Metabolism—PIK3CA—liver cancer	5.69e-06	1.89e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—KRAS—liver cancer	5.68e-06	1.89e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—MYC—liver cancer	5.6e-06	1.86e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—HRAS—liver cancer	5.6e-06	1.86e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—TGFB1—liver cancer	5.59e-06	1.86e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—HRAS—liver cancer	5.57e-06	1.85e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—VEGFA—liver cancer	5.55e-06	1.85e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—HRAS—liver cancer	5.54e-06	1.85e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—HRAS—liver cancer	5.54e-06	1.85e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—STAT3—liver cancer	5.5e-06	1.83e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—IL6—liver cancer	5.49e-06	1.83e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—AKT1—liver cancer	5.48e-06	1.82e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—VEGFA—liver cancer	5.37e-06	1.79e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—VEGFA—liver cancer	5.37e-06	1.79e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—IL6—liver cancer	5.36e-06	1.78e-05	CbGpPWpGaD
Perphenazine—CYP2B6—Metabolism—PIK3CA—liver cancer	5.33e-06	1.77e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—IL6—liver cancer	5.33e-06	1.77e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—STAT3—liver cancer	5.32e-06	1.77e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—STAT3—liver cancer	5.32e-06	1.77e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—PIK3CA—liver cancer	5.31e-06	1.77e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—IL6—liver cancer	5.31e-06	1.77e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—IL6—liver cancer	5.31e-06	1.77e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—AKT1—liver cancer	5.3e-06	1.76e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—AKT1—liver cancer	5.3e-06	1.76e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—PIK3CA—liver cancer	5.23e-06	1.74e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—PIK3CA—liver cancer	5.22e-06	1.74e-05	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—PIK3CA—liver cancer	5.19e-06	1.73e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PIK3CG—liver cancer	5.19e-06	1.73e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—KRAS—liver cancer	5.18e-06	1.72e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—PIK3CB—liver cancer	5.15e-06	1.71e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—TP53—liver cancer	5.14e-06	1.71e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—MYC—liver cancer	5.11e-06	1.7e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—TGFB1—liver cancer	5.1e-06	1.7e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—AKT1—liver cancer	5.06e-06	1.68e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—TP53—liver cancer	5.06e-06	1.68e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—TP53—liver cancer	5.05e-06	1.68e-05	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—PIK3CA—liver cancer	5.02e-06	1.67e-05	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—PIK3CA—liver cancer	5.02e-06	1.67e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PPARG—liver cancer	5.01e-06	1.67e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—MYC—liver cancer	4.94e-06	1.65e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—MYC—liver cancer	4.94e-06	1.65e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—AKT1—liver cancer	4.94e-06	1.64e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—TGFB1—liver cancer	4.93e-06	1.64e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—TGFB1—liver cancer	4.93e-06	1.64e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—AKT1—liver cancer	4.92e-06	1.64e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—HRAS—liver cancer	4.91e-06	1.64e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—AKT1—liver cancer	4.9e-06	1.63e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—AKT1—liver cancer	4.9e-06	1.63e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—HRAS—liver cancer	4.84e-06	1.61e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—HRAS—liver cancer	4.83e-06	1.61e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—PIK3CA—liver cancer	4.75e-06	1.58e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—KRAS—liver cancer	4.72e-06	1.57e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—IL6—liver cancer	4.7e-06	1.57e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Metabolism—AKT1—liver cancer	4.65e-06	1.55e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—IL6—liver cancer	4.63e-06	1.54e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—IL6—liver cancer	4.62e-06	1.54e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—TP53—liver cancer	4.6e-06	1.53e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—KRAS—liver cancer	4.57e-06	1.52e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—KRAS—liver cancer	4.57e-06	1.52e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PIK3CD—liver cancer	4.56e-06	1.52e-05	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—PIK3CA—liver cancer	4.51e-06	1.5e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—ALB—liver cancer	4.5e-06	1.5e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—HRAS—liver cancer	4.4e-06	1.46e-05	CbGpPWpGaD
Perphenazine—CYP2B6—Metabolism—AKT1—liver cancer	4.36e-06	1.45e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—AKT1—liver cancer	4.34e-06	1.44e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—PIK3CA—liver cancer	4.34e-06	1.44e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—AKT1—liver cancer	4.27e-06	1.42e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—AKT1—liver cancer	4.26e-06	1.42e-05	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—AKT1—liver cancer	4.24e-06	1.41e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—IL6—liver cancer	4.21e-06	1.4e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—TP53—liver cancer	4.2e-06	1.4e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—PIK3CA—liver cancer	4.2e-06	1.4e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—PIK3CA—liver cancer	4.2e-06	1.4e-05	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—AKT1—liver cancer	4.1e-06	1.36e-05	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—AKT1—liver cancer	4.1e-06	1.36e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—TP53—liver cancer	4.06e-06	1.35e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—TP53—liver cancer	4.06e-06	1.35e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—PIK3CA—liver cancer	4.03e-06	1.34e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—HRAS—liver cancer	4.01e-06	1.34e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PIK3CB—liver cancer	3.97e-06	1.32e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—AKT1—liver cancer	3.88e-06	1.29e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—HRAS—liver cancer	3.88e-06	1.29e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—HRAS—liver cancer	3.88e-06	1.29e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—IL6—liver cancer	3.84e-06	1.28e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—IL6—liver cancer	3.72e-06	1.24e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—IL6—liver cancer	3.72e-06	1.24e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—PIK3CA—liver cancer	3.71e-06	1.23e-05	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—AKT1—liver cancer	3.69e-06	1.23e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—PIK3CA—liver cancer	3.67e-06	1.22e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—AKT1—liver cancer	3.54e-06	1.18e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—AKT1—liver cancer	3.43e-06	1.14e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—AKT1—liver cancer	3.43e-06	1.14e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—AKT1—liver cancer	3.29e-06	1.1e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—PIK3CA—liver cancer	3.14e-06	1.04e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—AKT1—liver cancer	3.03e-06	1.01e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—AKT1—liver cancer	3e-06	9.99e-06	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—AKT1—liver cancer	2.56e-06	8.54e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PIK3CA—liver cancer	2.42e-06	8.06e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—AKT1—liver cancer	1.98e-06	6.59e-06	CbGpPWpGaD
